Cargando…
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery
BACKGROUND: Bariatric-metabolic surgery (BS) decreases the grade of steatosis, hepatic inflammation, and fibrosis in patients with severe obesity and non-alcoholic fatty liver disease (NAFLD). Mechanisms include substantial weight loss, but also simultaneous effects on glucose homeostasis. Therefore...
Autores principales: | Lautenbach, Anne, Wernecke, Marie, Mann, Oliver, Wagner, Jonas, Wolter, Stefan, Stoll, Fabian, Aberle, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889466/ https://www.ncbi.nlm.nih.gov/pubmed/36508157 http://dx.doi.org/10.1007/s11695-022-06406-0 |
Ejemplares similares
-
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
por: Lautenbach, Anne, et al.
Publicado: (2022) -
Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery
por: Lautenbach, Anne, et al.
Publicado: (2021) -
Bariatric Surgery Is Protective Against Renal Function Decline in Severely Obese Patients in the Long-Term
por: Lautenbach, Anne, et al.
Publicado: (2020) -
Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery
por: Lautenbach, Anne, et al.
Publicado: (2022) -
Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery
por: Chaiyasoot, Kusuma, et al.
Publicado: (2023)